Search Results - "Michotte, A."

Refine Results
  1. 1
  2. 2

    Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma by Duerinck, J., Du Four, S., Bouttens, F., Andre, C., Verschaeve, V., Van Fraeyenhove, F., Chaskis, C., D’Haene, N., Le Mercier, M., Rogiers, A., Michotte, A., Salmon, I., Neyns, B.

    Published in Journal of neuro-oncology (2018)
    “…Axitinib is a small molecule tyrosine kinase inhibitor with high affinity and specificity for the family of vascular endothelial growth factor receptors. It…”
    Get full text
    Journal Article
  3. 3

    Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma by Neyns, B., Sadones, J., Joosens, E., Bouttens, F., Verbeke, L., Baurain, J.-F., D'Hondt, L., Strauven, T., Chaskis, C., In't Veld, P., Michotte, A., De Greve, J.

    Published in Annals of oncology (01-09-2009)
    “…To evaluate the antitumor activity and toxicity of single-agent cetuximab in patients with recurrent high-grade glioma (HGG) after failure of surgery,…”
    Get full text
    Journal Article
  4. 4

    Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma by Duerinck, J., Du Four, S., Vandervorst, F., D’Haene, N., Le Mercier, M., Michotte, A., Van Binst, A. M., Everaert, H., Salmon, I., Bouttens, F., Verschaeve, V., Neyns, B.

    Published in Journal of neuro-oncology (01-05-2016)
    “…We conducted a randomized, non-comparative, multi center, phase II clinical trial in order to investigate the efficacy of axitinib, an oral small molecule…”
    Get full text
    Journal Article
  5. 5

    Phase II study of sunitinib malate in patients with recurrent high-grade glioma by Neyns, B., Sadones, J., Chaskis, C., Dujardin, M., Everaert, H., Lv, S., Duerinck, J., Tynninen, O., Nupponen, N., Michotte, A., De Greve, J.

    Published in Journal of neuro-oncology (01-07-2011)
    “…Receptor tyrosine kinase signaling causes profound neo-angiogenesis in high-grade gliomas (HGG). The KIT , PDGFR-α , and VEGFR2 genes are frequently amplified…”
    Get full text
    Journal Article
  6. 6

    Combination of support vector machines (SVM) and near-infrared (NIR) imaging spectroscopy for the detection of meat and bone meal (MBM) in compound feeds by Pierna, J. A. Fernández, Baeten, V., Renier, A. Michotte, Cogdill, R. P., Dardenne, P.

    Published in Journal of chemometrics (01-07-2004)
    “…This study concerns the development of a new system to detect meat and bone meal (MBM) in compound feeds, which will be used to enforce legislation concerning…”
    Get full text
    Journal Article
  7. 7

    Expression of thyroid transcription factor 1 in a chordoid glioma by Michotte, A, Van Der Veken, J, Huylebrouck, M, Duerinck, J, D'Haens, J, Hoorens, A

    Published in Journal of the neurological sciences (15-11-2014)
    “…Highlights • Expression of TTF-1 (Nkx2-1) is shown for the first time in a chordoid glioma. • Involvement of TTF-1 in signalling pathways of chordoid glioma…”
    Get full text
    Journal Article
  8. 8

    Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study by Chaskis, C, Stadnik, T, Michotte, A, Van Rompaey, K, D'Haens, J

    Published in Acta neurochirurgica (01-03-2006)
    “…Biopsy targeting based on MR imaging alone may fail to identify malignant areas in brain gliomas. Considering the differences in relative Cerebral Blood Volume…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Primary leptomeningeal anaplastic oligodendroglioma with a 1p36–19q13 deletion: Report of a unique case successfully treated with Temozolomide by Michotte, A, Chaskis, C, Sadones, J, Veld, P. In't, Neyns, B

    Published in Journal of the neurological sciences (15-12-2009)
    “…Abstract Primary leptomeningeal oligodendroglioma occurs very rarely and in only one patient a deletion of chromosome 1p has been reported. We describe a…”
    Get full text
    Journal Article
  11. 11

    Postischemic mild hypothermia reduces neurotransmitter release and astroglial cell proliferation during reperfusion after asphyxial cardiac arrest in rats by Hachimi-Idrissi, S, Van Hemelrijck, A, Michotte, A, Smolders, I, Sarre, S, Ebinger, G, Huyghens, L, Michotte, Y

    Published in Brain research (03-09-2004)
    “…The present study investigated whether postischemic mild hypothermia attenuates the ischemia-induced striatal glutamate (GLU) and dopamine (DA) release, as…”
    Get full text
    Journal Article
  12. 12

    Nasal heterotopia versus pilocytic astrocytoma: A narrow border by Ellouze, N, Born, J, Hoyoux, C, Michotte, A, Retz, C, Tebache, M, Piette, C

    Published in Neuro-chirurgie (01-08-2015)
    “…Abstract Failure of the anterior neuropore can lead to three main types of anomalies: nasal dermal sinus, encephalocele and nasal glioma or heterotopia. In…”
    Get full text
    Journal Article Web Resource
  13. 13
  14. 14

    Trigeminal Melanoma Metastasis by Tritschler, P., Rezazadeh Azar, A., De Coene, B., Maraite, N., Michotte, A.

    Published in Clinical neuroradiology (Munich) (01-03-2014)
    “…We present the case of a 70-year-old patient presented to our institution for paresthesia of the right hemiface associated with dysarthria in aggravation since…”
    Get full text
    Journal Article
  15. 15

    An Observational Study of the First Experience with Bevacizumab for the Treatment of Patients with Recurrent High-Grade Glioma in Two Belgian University Hospitals by D'Haens, J., Neyns, Bart, Huylebrouck, M., Lv, S., Duerinck, Johnny, Van Binst, A., Salmon, I., De Greve, J., De Witte, O., Luce, S., Michotte, Alex

    Published in Journal of Oncology (01-01-2012)
    “…Background. Bevacizumab (BEV), a humanized immunoglobulin G1 monoclonal antibody that inhibits VEGF has demonstrated activity against recurrent high-grade…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Increased Incidence of Sporadic Creutzfeldt-Jakob Disease in the Age Groups between 70 and 90 Years in Belgium by Van Everbroeck, B., Michotte, A., Sciot, R., Godfraind, C., Deprez, M., Quoilin, S., Martin, J.-J., Cras, P.

    Published in European journal of epidemiology (01-06-2006)
    “…From 1998 a prospective surveillance study of Creutzfeldt-Jakob disease (CJD) has been initiated in Belgium. In addition to epidemiological data, information…”
    Get full text
    Journal Article Web Resource
  18. 18
  19. 19

    DEGRADATION OF AROCLOR 1242 IN A SINGLE-STAGE COUPLED ANAEROBIC/AEROBIC BIOREACTOR by Tartakovsky, B, Michotte, A, Cadieux, J-C.A, Lau, P.C.K, Hawari, J, Guiot, S.R

    Published in Water research (Oxford) (01-12-2001)
    “…Degradation of Aroclor 1242 was studied in granular biofilm reactors with limited aeration. An aerobic biphenyl degrader, Rhodococcus sp. M5, was used to…”
    Get full text
    Journal Article
  20. 20

    Fatal Intracerebral Haemorrhage Following Carotid Endarterectomy in a Patient with Cerebral Amyloid Angiopathy by WILLEMS, S, DEBING, E, MICHOTTE, A, CHASKIS, C, VAN DEN BRANDE, P

    Published in Acta chirurgica belgica (01-03-2009)
    “…A 68-year-old man underwent carotid endarterectomy for symptomatic carotid artery stenosis. Immediately after surgery the patient suffered dramatic…”
    Get full text
    Journal Article